The medical records of 140 eyes of 140 consecutive open-angle glaucoma patients meeting eligibility criteria, all of whom had undergone SD-OCT imaging at the Glaucoma Clinic of Seoul National University Hospital between January 2012 and January 2013, were retrospectively reviewed. This study adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of Seoul National University Hospital.
All patients underwent a complete ophthalmic examination, including measurement of visual acuity, measurement of spherical equivalent, slit-lamp examination, measurement of intraocular pressure by Goldmann applanation tonometry, gonioscopy, fundoscopic examination with ≥5-mm pupil dilation, stereoscopic color-disc photography (SDP), red-free RNFL photography (RNFLP; Vx-10; Kowa Optimed, Tokyo, Japan), standard automated perimetry using Swedish interactive threshold algorithm 30-2 (Humphrey Field Analyzer II; Carl Zeiss Meditec, Inc., Dublin, CA, USA), and SD-OCT (Cirrus HD-OCT; Carl Zeiss Meditec, Inc.).
All patients had to meet the following criteria for inclusion: best corrected visual acuity (BCVA) ≥ 20/40, refractive error within ±5 diopters (D) in sphere and within ±3 D in cylinder, and a normal anterior chamber and open angle on slit-lamp and gonioscopic examinations. Patients with a history of ocular surgery other than simple cataract surgery, or any history or evidence of retinal pathology, diabetes mellitus, or nonglaucomatous optic neuropathy, were excluded.
Glaucomatous eyes were defined as those showing glaucomatous optic disc appearances (e.g., neuroretinal rim thinning, notching, and/or RNFL defects) and corresponding glaucomatous visual field defects, as confirmed by at least two consecutive visual fields. The glaucomatous visual field defects were defined as a cluster of ≥3 points with P < 0.05 on the pattern deviation map in at least one hemifield, including ≥1 point with P < 0.01; a pattern standard deviation (PSD) of P < 0.05; or glaucoma hemifield test result outside the normal limits. Only patients with reliable visual field test results (fixation loss < 20%, false-positive errors < 15%, and false-negative errors < 15%) were included. In cases in which both eyes of a patient were eligible, one was chosen randomly for inclusion.